These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2284952)

  • 21. Fibrin-stabilizing factor inhibitors. I. Amides and esters of trans-4-(aminomethyl)cyclohexane carboxylic acid (tranexamic acid).
    Nilsson JL; Stenberg P; Eriksson O; Lundén R
    Acta Pharm Suec; 1970 Sep; 7(4):441-8. PubMed ID: 5480084
    [No Abstract]   [Full Text] [Related]  

  • 22. A bifunctional monocyclic beta-lactam cross-links across the active site of beta-lactamase.
    Ahluwalia R; Day RA; Nauss J
    Biochem Biophys Res Commun; 1995 Jan; 206(2):577-83. PubMed ID: 7826374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and evaluation of some new benzimidazole derivatives as potential antimicrobial agents.
    Ansari KF; Lal C
    Eur J Med Chem; 2009 May; 44(5):2294-9. PubMed ID: 18316140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel imidazole substituted 6-methylidene-penems as broad-spectrum beta-lactamase inhibitors.
    Venkatesan AM; Agarwal A; Abe T; Ushirogochi H; Yamamura I; Kumagai T; Petersen PJ; Weiss WJ; Lenoy E; Yang Y; Shlaes DM; Ryan JL; Mansour TS
    Bioorg Med Chem; 2004 Nov; 12(22):5807-17. PubMed ID: 15498657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigravitropic activity of 2-(2-arylamino-1,2-dioxoethyl) benzoic acid methyl esters.
    Modena T; Pavanetto F; Mazza M
    Farmaco; 1994 Oct; 49(10):667-70. PubMed ID: 7826475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Why clinically used tazobactam and sulbactam are poor inhibitors of OXA-10 beta-lactamase: Raman crystallographic evidence.
    Totir MA; Cha J; Ishiwata A; Wang B; Sheri A; Anderson VE; Buynak J; Mobashery S; Carey PR
    Biochemistry; 2008 Apr; 47(13):4094-101. PubMed ID: 18324783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Determination of the beta-lactamase-inhibiting capacity of different compounds by using a penicillinase-forming strain of Staphylococcus aureus 5A].
    Nikishina VG; Ivanitskaia LP; Bibikova MV
    Antibiotiki; 1981 Oct; 26(10):735-40. PubMed ID: 6975597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of 3-Substituted-clavams: Antifungal Properties, DD-Peptidase and beta-Lactamase Inhibition.
    Cierpucha M; Panfil I; Danh TT; Chmielewski M; Kurzatkowski W; Rajnisz A; Solecka J
    J Antibiot (Tokyo); 2007 Oct; 60(10):622-32. PubMed ID: 17965478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel chymase inhibitor, 4-[1-([bis-(4-methyl-phenyl)-methyl]-carbamoyl)3-(2-ethoxy-benzyl)-4-oxo-azetidine-2-yloxy]-benzoic acid (BCEAB), suppressed cardiac fibrosis in cardiomyopathic hamsters.
    Takai S; Jin D; Sakaguchi M; Katayama S; Muramatsu M; Sakaguchi M; Matsumura E; Kim S; Miyazaki M
    J Pharmacol Exp Ther; 2003 Apr; 305(1):17-23. PubMed ID: 12649348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacteriological investigations with beta-lactamase inhibitors.
    Ullmann U
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):222-9. PubMed ID: 6289565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Beta-lactamase inhibitors. II. Synthesis and biological properties of 6-sulfonylaminopenicillanic acids].
    Kazimierczak J; Mikołajczyk J; Kotulowa W; Cieślak J
    Acta Pol Pharm; 1984; 41(6):619-23. PubMed ID: 6100225
    [No Abstract]   [Full Text] [Related]  

  • 32. Syntheses and complement inhibitory activities of 4-(2-phenyl-1H-indol-3-yl)cyclohexane-1-carboxylic acids.
    Bailey DM; DeGrazia GD; Alexander EJ; Powles RG; Johnson RE; Patrick RA; Heerdt BG; Fairbain ME; Pruden DJ
    J Med Chem; 1985 Feb; 28(2):160-4. PubMed ID: 3155799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Synthesis of some derivatives of 2-methyl-4-(2',2',6'-trimethyl-cyclohexyl)-butane-1-carboxylic acid].
    Zawisza T
    Acta Pol Pharm; 1975; 32(1):15-24. PubMed ID: 1114908
    [No Abstract]   [Full Text] [Related]  

  • 34. [Inhibitory effect of 4-(2-carboxyethyl) phenyl trans-4-aminomethyl cyclohexane carboxylate hydrochloride on fibrinolysis, esterolysis and proteolysis and its degradation by serum esterases: in vitro study].
    Nagamatsu Y; Matsumoto M; Yamamoto J; Okamoto U
    Nihon Ketsueki Gakkai Zasshi; 1973 Apr; 36(2):150-8. PubMed ID: 4738466
    [No Abstract]   [Full Text] [Related]  

  • 35. Generating rapamycin analogues by directed biosynthesis: starter acid substrate specificity of mono-substituted cyclohexane carboxylic acids.
    Goss RJ; Lanceron SE; Wise NJ; Moss SJ
    Org Biomol Chem; 2006 Nov; 4(22):4071-3. PubMed ID: 17312960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential fibrinolytic agents: versatile synthetic route to novel 4-(branched alkyl)benzoic acids via beta-monosubstituted or beta,beta-disubstituted styrene-4-carboxylic acids.
    Loeffler LJ; Delorefice SB
    J Pharm Sci; 1975 Jul; 64(7):1170-3. PubMed ID: 1151678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The synthesis of 4'-(2-carboxyethyl)phenyl trans-4-aminomethyl cyclohexane carboxylate hydrochloride (cetraxate hydrochloride) by means of enzymatic debenzylation].
    Kuroda H; Miyadera A; Kaneuchi T; Imura A
    Yakugaku Zasshi; 1989 Mar; 109(3):157-62. PubMed ID: 2754616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of a broad array of highly functionalized, enantiomerically pure cyclohexanecarboxylic acid derivatives by microbial dihydroxylation of benzoic acid and subsequent oxidative and rearrangement reactions.
    Myers AG; Siegel DR; Buzard DJ; Charest MG
    Org Lett; 2001 Sep; 3(18):2923-6. PubMed ID: 11529791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. beta-Lactamase inhibitors derived from N-tosyloxy-beta-lactams.
    Teng M; Miller MJ; Nicas TI; Grissom-Arnold J; Cooper RD
    Bioorg Med Chem; 1993 Aug; 1(2):151-4. PubMed ID: 8081845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of the optical isomers of 4-[1-(4-tert-butylphenyl)-2-oxo- pyrrolidine-4-yl]methyloxybenzoic acid (S-2) and their biological evaluation as antilipidemic agent.
    Ohno T; Yano S; Yamada H; Shirasaka T; Yamamoto A; Kobayashi K; Ogawa K
    Chem Pharm Bull (Tokyo); 1999 Nov; 47(11):1549-54. PubMed ID: 10605053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.